Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

Sophie Krieger 1 Mirjam Zeisel 1 Christopher Davis 2 Christine Thumann 1 Helen Harris 2 Eva Schnober 3 Christopher Mee 2 Eric Soulier 1 Cathy Royer 1 Mélanie Lambotin 1 Fritz Grunert 4 Viet Loan Dao Thi 5 Marlène Dreux 5 François-Loïc Cosset 5 Jane Mckeating 2 Catherine Schuster 1 Thomas Baumert 6, 1, *
* Auteur correspondant
1 Interaction virus-hôte et maladies du foie
2 Hepatitis C Research Group
3 Department of Medicine II
4 Aldevron GmbH
5 Virologie humaine
6 Service d'Hépato-gastroentérologie
Abstract : The tight junction protein claudin-1 (CLDN1) has been shown to be essential for hepatitis C virus (HCV) entry-the first step of viral infection. Due to the lack of neutralizing anti-CLDN1 antibodies, the role of CLDN1 in the viral entry process is poorly understood. In this study, we produced antibodies directed against the human CLDN1 extracellular loops by genetic immunization and used these antibodies to investigate the mechanistic role of CLDN1 for HCV entry in an infectious HCV cell culture system and human hepatocytes. Antibodies specific for cell surface-expressed CLDN1 specifically inhibit HCV infection in a dose-dependent manner. Antibodies specific for CLDN1, scavenger receptor B1, and CD81 show an additive neutralizing capacity compared with either agent used alone. Kinetic studies with anti-CLDN1 and anti-CD81 antibodies demonstrate that HCV interactions with both entry factors occur at a similar time in the internalization process. Anti-CLDN1 antibodies inhibit the binding of envelope glycoprotein E2 to HCV permissive cell lines in the absence of detectable CLDN1-E2 interaction. Using fluorescent-labeled entry factors and fluorescence resonance energy transfer methodology, we demonstrate that anti-CLDN1 antibodies inhibit CD81-CLDN1 association. In contrast, CLDN1-CLDN1 and CD81-CD81 associations were not modulated. Taken together, our results demonstrate that antibodies targeting CLDN1 neutralize HCV infectivity by reducing E2 association with the cell surface and disrupting CD81-CLDN1 interactions. Conclusion: These results further define the function of CLDN1 in the HCV entry process and highlight new antiviral strategies targeting E2-CD81-CLDN1 interactions.
Keywords : tight junction receptor polarization infection hepatocyte
Type de document :
Article dans une revue
Hepatology, Wiley-Blackwell, 2010, 51 (4), pp.1144-57. 〈10.1002/hep.23445〉
Liste complète des métadonnées

Littérature citée [4 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00705657
Contributeur : Thomas Baumert <>
Soumis le : vendredi 8 juin 2012 - 09:58:08
Dernière modification le : jeudi 21 décembre 2017 - 01:04:22
Document(s) archivé(s) le : jeudi 15 décembre 2016 - 12:25:03

Fichier

Krieger_et_al._Hepatology_2010...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

ENS-LYON

Citation

Sophie Krieger, Mirjam Zeisel, Christopher Davis, Christine Thumann, Helen Harris, et al.. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.. Hepatology, Wiley-Blackwell, 2010, 51 (4), pp.1144-57. 〈10.1002/hep.23445〉. 〈inserm-00705657〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

361

Téléchargements de fichiers

264

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD